MENU
BHVN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Biohaven (BHVN) Earnings Date & Reports
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
BHVN is expected to report earnings to fall 76.74% to -20 cents per share on March 08
Q4'26
Est.
$-0.20
Q3'26
Missed
by $0.06
Q2'26
Missed
by $0.03
Q1'26
Missed
by $0.04
Q4'25
Beat
by $0.28
The last earnings report on October 29 showed earnings per share of -86 cents, missing the estimate of -80 cents. With 2.02M shares outstanding, the current market capitalization sits at 2.36B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical drugs
Industry Biotechnology
Industry
Pharmaceuticals Major
Address
c/o Biohaven Pharmaceuticals, Inc
Phone
+1 203 404-0410
Employees
274
Web
https://www.biohaven.com